Form 4: Ginkgo Bioworks Executive Steven P. Coen Reports Acquisition of 300,000 Restricted Stock Units
SEC Form 4 Filing
Steven P. Coen, Chief Accounting Officer of Ginkgo Bioworks Holdings, Inc., reports the acquisition of 300,000 Restricted Stock Units (RSUs) on March 7, 2024, vesting over a period beginning May 1, 2024.
Summary
- On March 8, 2024, a Form 4 filing with the SEC revealed that Steven P. Coen, Chief Accounting Officer of Ginkgo Bioworks Holdings, Inc., acquired 300,000 Restricted Stock Units (RSUs) on March 7, 2024.
- Each RSU represents a contingent right to receive one share of Ginkgo Bioworks' Class A Common Stock.
- The RSUs vest in installments, with 2/48ths of the underlying shares vesting on May 1, 2024, followed by 46 equal monthly installments thereafter.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a standard disclosure of executive compensation and doesn't inherently indicate positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and is typical for publicly traded companies. It provides transparency regarding the equity-based compensation of key personnel.
Stakeholder Impact
- The granting of RSUs aligns the executive's interests with those of the shareholders, as the value of the RSUs is tied to the company's stock performance.
Key Dates
| Date | Description |
|---|---|
| 03/07/2024 | Date of transaction: Steven P. Coen acquired 300,000 Restricted Stock Units. |
| 03/08/2024 | Date of Form 4 Filing. |
| 05/01/2024 | First vesting date for the RSUs; 2/48ths of the shares vest. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.